ImportantUpdates
Medicamen Biotech's Board has proposed a final dividend for FY25-26, awaiting shareholder approval at the 33rd AGM.
Medicamen Biotech LimitedMEDICAMEQ · Filed with the exchange
Book closure and record date for dividend eligibility are set.
No comments yet. Be the first.